Solid Tumor Recruiting Phase 1 Trials for Carboplatin (DB00958)

Also known as: Cancer - Solid Tumors / Solid Tumour / Solid Tumours / Tumor, Solid / Solid Neoplasms / Solid tumour/cancer / Solid Cancers / Cancer: Solid Tumors / Neoplasms, Solid Tumor / Cancer, Solid Tumor / Tumors, Solid / Solid Tumor Cancer / Solid Tumors or Cancers / Solid Tumors / Solid Neoplasm / Cancer (Solid Tumors) / Solid Tumor Neoplasms / Solid Tumor Cancers / Solid Cancer / Neoplasm / Neoplasm (morphologic abnormality) / Neoplasms of unspecified behavior / Neoplasms NOS / Neoplasms NOS (disorder) / [M]Neoplasms NOS (morphologic abnormality) / Neoplasm (NOS) / Tumor / Neoplasm NOS / Tumour / Tumour NOS / Neoplasms / Tumour, NOS / Tumor NOS / Neoplasm, NOS / Tumor, NOS / Neoplasms benign, malignant and unspecified (incl cysts and polyps)

IndicationStatusPhase
DBCOND0030180 (Solid Tumor)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04823897
A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid TumoursTreatment
NCT05382559
A Study of ASP3082 in Adults With Advanced Solid TumorsTreatment
NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Treatment
NCT07174583
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerTreatment
NCT05144698
RAPA-201 Therapy of Solid TumorsTreatment
NCT07466160
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid TumorsTreatment
NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsTreatment
NCT04516447
A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerTreatment
NCT07730021
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsTreatment
NCT05067283
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Treatment
NCT05719558
A Study of ASP1002 in Adults for Treatment of Solid TumorsTreatment
NCT06162221
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCTreatment
NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsTreatment
NCT06336707
HS-20089 Combination Treatment in Subjects With Advanced Solid TumorsTreatment
NCT06943820
AK129 Combination Therapy for Advanced Solid TumorsTreatment
NCT05315700
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationTreatment
NCT04999761
AB122 Platform StudyTreatment
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisTreatment
NCT07381829
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung CancerTreatment